| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/26/2005 | US6884433 Time release agents comprising drugs such as tacrolimus in solid solutions |
| 04/26/2005 | US6884412 Dectection of and methods and composition for prevention and/or treatment of papillomatous digital dermatitis |
| 04/26/2005 | US6884356 Low-level boron detection and measurement |
| 04/26/2005 | US6884223 Method for detecting α-oxoaldehydes in the whole blood, blood plasma and/or serum of a patient |
| 04/26/2005 | US6883958 For collecting and processing specimens of particulate matter-containing biological fluid, including depositing onto microscope slide or other surface a uniform layer of particulates therefrom (e.g., cells); diagnostic cytology |
| 04/26/2005 | US6883559 Method and apparatus for gradient generation |
| 04/26/2005 | US6883364 Portable sensor |
| 04/26/2005 | CA2395627C Imaging and analyzing parameters of small moving objects such as cells |
| 04/26/2005 | CA2391178C Dual riser/single capillary viscometer |
| 04/26/2005 | CA2310854C Isolation and identification of novel polymerases |
| 04/26/2005 | CA2262215C Discrete quantitative structure activity relationships |
| 04/26/2005 | CA2253871C Ret ligand (retl) for stimulating neural and renal growth |
| 04/26/2005 | CA2175689C Assay device with a barrier for regulating reagent application |
| 04/26/2005 | CA2165954C Prostaglandin receptor fp and dna encoding it |
| 04/22/2005 | CA2485722A1 Soluble transferrin receptor |
| 04/22/2005 | CA2485718A1 Differential diagnosis with hepcidin |
| 04/21/2005 | WO2005036602A2 Integrated biochip with continuous sampling and processing (csp) system |
| 04/21/2005 | WO2005036442A1 DEVICE AND METHOD FOR PREDICTING RNAi EFFECT IN siRNA |
| 04/21/2005 | WO2005036181A1 A method for characterizing a dispersion using transformation techniques |
| 04/21/2005 | WO2005036180A1 Analysis methods using biomarkers concentrated with biomarkers attractant molecules |
| 04/21/2005 | WO2005036179A1 Assays for evaluating anti-osteoarthritic activity |
| 04/21/2005 | WO2005036178A1 Fluorescence indicator utilizing fret |
| 04/21/2005 | WO2005036177A2 Peptide and assay |
| 04/21/2005 | WO2005036176A1 Cell surface molecules as markers and therapeutic agents against kidney cancers |
| 04/21/2005 | WO2005036175A2 Sensors employing combinatorial artificial receptors |
| 04/21/2005 | WO2005036174A1 Method of calibrating ligand specificity |
| 04/21/2005 | WO2005036173A1 Method of removing nonspecific substances |
| 04/21/2005 | WO2005036172A1 Method of high-speed detection for biological analyte |
| 04/21/2005 | WO2005036171A1 Method and system for detection of a target analyte |
| 04/21/2005 | WO2005036170A2 Device for separating and/ analysing several molecular targets dissolved in a complex mixture |
| 04/21/2005 | WO2005036169A2 Fluorescent probes for ribosomes and method of use |
| 04/21/2005 | WO2005036168A2 Method of detecting biological materials in liquid |
| 04/21/2005 | WO2005036167A1 Method and apparatus for detecting analyte with filter |
| 04/21/2005 | WO2005036166A1 Automatic analysis device and method for monitoring polymer production by means of mass spectrometry |
| 04/21/2005 | WO2005036165A1 Screening method of formulating a pharmaceutical composition by using model compounds |
| 04/21/2005 | WO2005036164A1 Reference control for optical measurement of nucleated red blood cells of a blood sample |
| 04/21/2005 | WO2005036158A1 Electrochemical sensor |
| 04/21/2005 | WO2005036157A1 Multisensor microchip which is used to measure gas flow, temperature and concentration in order to control combustion, production method thereof and use of same |
| 04/21/2005 | WO2005036153A1 Improved isoelectric focusing gels and methods of use thereof |
| 04/21/2005 | WO2005036138A1 System, kit, and method for measuring membrane diffusion |
| 04/21/2005 | WO2005036127A2 Methods and compositions for identifying target cell cytolytic lymphocytes in a sample |
| 04/21/2005 | WO2005036123A2 Methods for substantially simultaneous evaluation of a sample containing a cellular target and a soluble analyte |
| 04/21/2005 | WO2005035862A1 Method for processing signals obtained by scanning planar textile structures |
| 04/21/2005 | WO2005035783A1 Fluorescense based bioassay for anti-parasitic drugs |
| 04/21/2005 | WO2005035782A1 Method of classifying chemical agents and identifying cellular targets thereof |
| 04/21/2005 | WO2005035780A1 Novel method of screening indicator substance |
| 04/21/2005 | WO2005035751A1 Method of quickly and efficiently selecting high-functioning protein, high-functioning protein thus obtained, method of producing the same and method of using the same |
| 04/21/2005 | WO2005035722A2 Variant polypeptides containing plekstrin homology domains and uses therefor |
| 04/21/2005 | WO2005035721A2 Native immunoglobulin binding reagents and methods for making and using same |
| 04/21/2005 | WO2005035720A2 Methods and use of binding components for improving assay specificity |
| 04/21/2005 | WO2005035579A1 A method for the treatment of maligant diseases by inhibiting nucleolin |
| 04/21/2005 | WO2005035568A1 Peptidomimetics and uses thereof |
| 04/21/2005 | WO2005035554A1 Dioxin-binding material and method of detecting or quantifying dioxin |
| 04/21/2005 | WO2005035552A2 Transducing combinatorial peptide library |
| 04/21/2005 | WO2005035113A1 Magnetically operated absorbent and method for the production thereof |
| 04/21/2005 | WO2005034995A1 Prion chimeras and uses thereof |
| 04/21/2005 | WO2005034926A2 Non-invasive system for detecting skin cancer |
| 04/21/2005 | WO2005034876A2 Use of cell lines to produce active therapeutic proteins |
| 04/21/2005 | WO2005034840A2 Identification of kinase inhibitors |
| 04/21/2005 | WO2005034737A2 Methods for diagnosing and treating endoplasmic reticulum (er) stress diseases |
| 04/21/2005 | WO2005034736A2 Generation of biochemical images and methods of use |
| 04/21/2005 | WO2005034735A2 Method for assessing the risk for insulin resistant diabetes and/or heart disease |
| 04/21/2005 | WO2005034733A2 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
| 04/21/2005 | WO2005034732A2 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 04/21/2005 | WO2005034625A1 Covalently attached collagen vi for cell attachment and proliferation |
| 04/21/2005 | WO2005025310A3 MODEL SYSTEM FOR TCR ξ CHAIN DOWNREGULATION |
| 04/21/2005 | WO2005022161B1 Chemiluminescent compounds |
| 04/21/2005 | WO2005019427A3 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals |
| 04/21/2005 | WO2005019110A3 Inorganic carbon removal |
| 04/21/2005 | WO2005017197A3 Method for early detection and monitoring of diseases by analysis of cell-surface-bound nucleic acids |
| 04/21/2005 | WO2005017129B1 Phosphoramide and uses thereof |
| 04/21/2005 | WO2005012913A3 Method for demonstration of a molecular event in a cell by means of fluorescent marker proteins |
| 04/21/2005 | WO2005012509A3 Method for immunotherapy of tumors |
| 04/21/2005 | WO2005010542A3 On-chip magnetic particle sensor with improved snr |
| 04/21/2005 | WO2005007677A3 Affinity capture of peptides by microarray and related methods |
| 04/21/2005 | WO2005005478A3 Diagnostics and therapeutics for diseases associated with g protein-coupled opioid receptor; delta 1 (oprd1) |
| 04/21/2005 | WO2005003776A3 In vitro methods for detecting renal cancer |
| 04/21/2005 | WO2005003730A9 Sensors |
| 04/21/2005 | WO2005001461A3 Biosensor and method of preparation |
| 04/21/2005 | WO2004113924A3 Method and system for generating and capturing peptides on a target surface |
| 04/21/2005 | WO2004111610A3 Method and system for the analysis of high density cells samples |
| 04/21/2005 | WO2004109286A3 Methods for detecting and treating cancer using podocalyxin and/or endoglycan |
| 04/21/2005 | WO2004108902A3 Biocompatible fluorescent silicon nanoparticles |
| 04/21/2005 | WO2004108888A3 Micropositioning cells for tissue engineering |
| 04/21/2005 | WO2004108142A3 Inhibitors of tip-1 for treatment tissue damage |
| 04/21/2005 | WO2004104594A3 Light emitting probes |
| 04/21/2005 | WO2004101769A3 Proteins, sensors, and methods of characterizing analytes using the same |
| 04/21/2005 | WO2004096987A3 A forward mutation assay based on 5-fluorouracil resistance |
| 04/21/2005 | WO2004094992A3 Methods for analysis of biological dataset profiles |
| 04/21/2005 | WO2004093995A3 Use of antioxidants to treat bone loss disorders |
| 04/21/2005 | WO2004092734A3 Novel approach to molecular diagnosis of human papilloma virus-related diseases |
| 04/21/2005 | WO2004092730A3 Method and device for detecting the presence of an analyte |
| 04/21/2005 | WO2004089423A3 Pharmico-gene theraphy of epithelial sodium channel associated disoders |
| 04/21/2005 | WO2004087746A3 Staphylococcus epidermidis antigens |
| 04/21/2005 | WO2004078918A3 Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides |
| 04/21/2005 | WO2004078594A3 Ligand/binding partner bio-labeling systems |
| 04/21/2005 | WO2004073657A3 Methods of diagnosis of cancer and other diseases, composition and methods of screening for modulators of cancer and other diseases |
| 04/21/2005 | WO2004072256A3 Variants of cytochrome c and methods of diagnostics of thrombocytopenia |
| 04/21/2005 | WO2004071462A3 Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction |
| 04/21/2005 | WO2004066937A3 Antibodies specific for plasmacytoid dendritic cells |